104 results
8-K
EX-99.6
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
must contain a pediatric assessment unless the sponsor has received a deferral or waiver. The required assessment must evaluate the safety … begin. The FDA must send a non-compliance letter to any sponsor that fails to submit the required assessment, keep a deferral current or fails
8-K
EX-99.3
ay7 7efq9du
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
izj acp7plhps7
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
8lte sp6hqqm3x9h
10 Nov 22
Prospectus supplement
4:21pm
425
chuf 5layoz2bs
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.2
e2y14x77ig
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.1
jgwrceknuaeoznbo9
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm